Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1999
05/25/1999CA2111178C Food composition
05/25/1999CA2067371C Stable hemoglobin based composition and method to store same
05/25/1999CA1340555C Oral vaccines
05/21/1999CA2251257A1 Oncogene- or virus-controlled expression systems
05/20/1999WO1999024836A1 125 human secreted proteins
05/20/1999WO1999024613A1 Human blood bacterium
05/20/1999WO1999024610A1 Novel genes encoding transporter-like molecules
05/20/1999WO1999024601A1 Secreted protein nsl4
05/20/1999WO1999024589A2 Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof
05/20/1999WO1999024587A2 Human phospholipase a2 protein and dna encoding it
05/20/1999WO1999024583A1 Dna demethylase, therapeutic and diagnostic uses thereof
05/20/1999WO1999024582A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
05/20/1999WO1999024580A2 Essential fungal genes and their use
05/20/1999WO1999024579A1 Novel era
05/20/1999WO1999024578A2 Neisserial antigens
05/20/1999WO1999024577A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
05/20/1999WO1999024576A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
05/20/1999WO1999024572A1 Genes with restricted expression in mesencephalic dopaminergic neurons
05/20/1999WO1999024571A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
05/20/1999WO1999024569A1 Human lysophosphatidic acid receptor and use thereof
05/20/1999WO1999024567A1 Tissue cement proteins from rhipicephalus appendiculatus
05/20/1999WO1999024566A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis
05/20/1999WO1999024565A1 Methods and compositions for immunomodulation
05/20/1999WO1999024560A1 Compositions and methods for inhibiting the activity of certain genes
05/20/1999WO1999024559A2 Nuclear targeting by means of streptococcal protein h
05/20/1999WO1999024557A1 Human bone accessory cells
05/20/1999WO1999024553A2 X-ray crystal comprising hiv-1 gp120
05/20/1999WO1999024490A1 Strictly alternating poly(alkylene oxide ether) copolymers
05/20/1999WO1999024470A1 Mammalian milk growth factor
05/20/1999WO1999024469A1 Secreted proteins and polynucleotides encoding them
05/20/1999WO1999024468A1 An alzheimer-related, endothelium-derived toxic factor and methods for its use
05/20/1999WO1999024467A1 IgG-BINDING PROTEIN FROM STAPHYLOCOCCUS AND NUCLEOTIDE SEQUENCE ENCODING THIS PROTEIN
05/20/1999WO1999024463A2 Signal peptide-containing proteins
05/20/1999WO1999024462A2 Novel conjugates of rgd-containing peptides and endogenous carriers
05/20/1999WO1999024461A1 Clostridial toxin inhibitors and pharmaceutical compositions containing same
05/20/1999WO1999024460A2 Dipeptide nitriles
05/20/1999WO1999024442A1 Novel signal transduction inhibitors, compositions containing them
05/20/1999WO1999024401A1 Use of alkylated iminosugars to treat multidrug resistance
05/20/1999WO1999024391A1 Radio-opaque polymer biomaterials
05/20/1999WO1999024107A1 Biodegradable, anionic polymers derived from the amino acid l-tyrosine
05/20/1999WO1999024076A2 Salicylate derivatized therapeutic and diagnostic agents
05/20/1999WO1999024075A2 Affinity markers for human serum albumin
05/20/1999WO1999024074A2 Novel conjugates of opioids and endogenous carriers
05/20/1999WO1999024071A1 Method for decreasing self-association of polypeptides
05/20/1999WO1999024069A1 Preventives and remedies for diffuse lung diseases
05/20/1999WO1999024067A1 Micobacterium vaccae preparation comprising cold-shock proteins and its use in therapy
05/20/1999WO1999024066A2 Methods and compositions for enhancing immune response and for the production of in vitro mabs
05/20/1999WO1999024063A1 Compositions providing for increased igf-i solubility
05/20/1999WO1999024062A1 Novel igf-i composition and its use
05/20/1999WO1999024061A1 Method for producing igf-1 sustained-release formulations
05/20/1999WO1999024060A1 Interferon immunotherapy
05/20/1999WO1999024059A1 Pdgf-mediated microvascular communication and methods of use thereof
05/20/1999WO1999024058A2 Neuronal uses of bmp-11
05/20/1999WO1999024057A2 Neuronal uses of bmp-11
05/20/1999WO1999024056A1 Regulation of ocular angiogenesis
05/20/1999WO1999024055A1 Therapeutic molecules
05/20/1999WO1999024054A1 Host derived proteins binding hcv: medical, diagnostic and purification use
05/20/1999WO1999024053A1 Enhanced opening of abnormal brain tissue capillaries
05/20/1999WO1999024052A2 Use of protein h as cytostatic agent
05/20/1999WO1999024051A2 Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear
05/20/1999WO1999024045A1 Methods for treatment of tumors and tumor cells using ex vivo activated t cells
05/20/1999WO1999024044A1 Medicine for promoting cicatrization and containing thrombocytes
05/20/1999WO1999024036A1 Skin penetration enhancing components
05/20/1999WO1999024019A1 Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
05/20/1999WO1999024015A1 Buffered drug formulations for transdermal electrotransport delivery
05/20/1999WO1999023967A1 Use of hemoglobin to treat systemic inflammatory response syndrome
05/20/1999WO1999023879A1 Method for the augmentation of gene expression
05/20/1999WO1999023867A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use
05/20/1999WO1999018213A8 MUTANTS OF YEAST Cdc24p, DEFECTIVE IN BINDING OF THE G-PROTEIN BETA SUBUNIT
05/20/1999WO1999016871A3 Nucleic acid catalysts with endonuclease activity
05/20/1999WO1999016791A3 Compounds and methods for regulating cell adhesion
05/20/1999WO1999015665A3 Mutants of thyroid stimulating hormone and methods based thereon
05/20/1999WO1999015653A3 Tie ligand homologues
05/20/1999WO1999015649A3 Composition and method for enhancing paracellular transport across cell layers
05/20/1999WO1999015553A3 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
05/20/1999WO1999015191A3 Cytokines having neurotrophic activity
05/20/1999WO1999011666B1 N-terminal modifications of rantes and methods of use
05/20/1999WO1999010494A3 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
05/20/1999WO1999010369A9 Compositions, kits, and methods for effecting adenine nucleotide modulation of dna mismatch recognition proteins
05/20/1999WO1999009182A3 Rab proteins
05/20/1999WO1999009167A8 Porcine mhc class i genes and uses thereof
05/20/1999WO1999008718A3 Bioresorbable compositions for implantable prostheses
05/20/1999WO1999007736A3 Lipoprotein-regulating medicaments
05/20/1999WO1999007734A3 Hepatitis c inhibitor peptide analogues
05/20/1999WO1999007733A3 Hepatitis c inhibitor peptides
05/20/1999WO1999006557A3 Mammalian cell membrane proteins; related reagents
05/20/1999WO1999006549B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES
05/20/1999WO1999001118A9 Antioxidant enhancement of therapy for hyperproliferative conditions
05/20/1999WO1998051788A3 Method and construct for inhibition of cell migration
05/20/1999WO1998048785A9 Allelic polygene diagnosis of reward deficiency syndrome and treatment
05/20/1999WO1998031796A8 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons
05/20/1999WO1998024806B1 Substituted oxadiazole, thiadiazole and triazole serine protease inhibitors
05/20/1999WO1998013007A8 Methods and compositions for lipidization of hydrophilic molecules
05/20/1999DE19750328A1 Antitumor agent containing bromelain plus vitamin C and/or E and/or silicic and/or acetylsalicylic acid
05/20/1999CA2671261A1 Neisserial antigens
05/20/1999CA2628053A1 Affinity markers for human serum albumin
05/20/1999CA2319380A1 Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
05/20/1999CA2310575A1 Method for the augmentation of gene expression
05/20/1999CA2310213A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
05/20/1999CA2309955A1 Method for decreasing self-association of polypeptides
1 ... 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 ... 3163